Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for NRIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
May 31, 2026 132.91M
February 28, 2026 155.24M
November 30, 2025 163.82M
August 31, 2025 150.22M
May 31, 2025 143.95M
February 28, 2025 134.13M
November 30, 2024 148.44M
August 31, 2024 136.74M
May 31, 2024 140.34M
February 29, 2024 143.93M
November 30, 2023 164.05M
August 31, 2023 74.38M
May 31, 2023 90.70M
February 28, 2023 96.10M
Date Value
November 30, 2022 116.36M
August 31, 2022 116.79M
May 31, 2022 127.57M
February 28, 2022 131.80M
November 30, 2021 137.80M
August 31, 2021 117.86M
May 31, 2021 119.80M
February 28, 2021 126.53M
November 30, 2020 106.07M
August 31, 2020 104.25M
May 31, 2020 274.80M
February 29, 2020 158.59M
November 30, 2019 53.57M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Monte Rosa Therapeutics, Inc. 203.88M
Gilead Sciences, Inc. 37.62B
TG Therapeutics, Inc. 1.036B
Cue Biopharma, Inc. 28.40M
Keros Therapeutics, Inc. 25.28M

Total Liabilities (Quarterly) Related Metrics